Stocksigma LogoStocksigma Logo

CRISIL Assigns 'Strong' ESG Rating of 61 to Aarti Drugs

Crisil ESG Ratings & Analytic Limited has assigned an Environmental, Social, and Governance (ESG) rating of 'Crisil ESG 61' (Strong) to Aarti Drugs Limited

CRISIL Assigns 'Strong' ESG Rating of 61 to Aarti Drugs

Aarti Drugs Ltd 路 Others (Uncategorized) 路 09 Oct 2026, 12:51 am

CRISIL Assigns 'Strong' ESG Rating of 61 to Aarti Drugs Crisil ESG Ratings & Analytic Limited has assigned an Environmental, Social, and Governance (ESG) rating of 'Crisil ESG 61' (Strong) to Aarti Drugs Limited based on FY'26 data. The report, received by the company on 7th Oct'26, was prepared independently by the SEBI-registered Category-1 ESG rating provider using publicly available information without direct engagement from Aarti Drugs.

Original exchange filing (PDF)

More announcements from Aarti Drugs Ltd

All Aarti Drugs Ltd announcements